ROsuvastatin Pretreatment to Reduce MyocArdial Periprocedural Necrosis:Comparison With Atorvastatin Reloading
Condition(s):Assess the Periprocedural Myocardial NecrosisLast Updated:January 4, 2013Completed
Hide Studies Not Open or Pending
Condition(s):Assess the Periprocedural Myocardial NecrosisLast Updated:January 4, 2013Completed
Condition(s):Migraine; Aura; Patent Foramen OvaleLast Updated:January 25, 2008Unknown status
Condition(s):Cardiac Arrest; Hypoxic Ischemic Brain InjuryLast Updated:February 18, 2021Terminated
Condition(s):Primary Ciliary Dyskinesia; Kartagener SyndromeLast Updated:November 30, 2023Recruiting
Condition(s):Angina PectorisLast Updated:February 9, 2012Completed
Condition(s):Acute Myocardial InfarctionLast Updated:July 27, 2022Completed
Condition(s):Acute Myocardial InfarctionLast Updated:December 4, 2015Withdrawn
Condition(s):STEMI – ST Elevation Myocardial Infarction; CADLast Updated:December 20, 2023Terminated
Condition(s):Hemorrhage, Gastrointestinal; Myocardial Infarction; Stroke; Kidney DiseasesLast Updated:October 11, 2016Completed
Condition(s):Cerebrovascular Accident; Stroke, Acute; Cerebral StrokeLast Updated:April 9, 2021Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.